Downat

Downat may be available in the countries listed below.

Ingredient matches for Downat

Prazosin

Prazosin hydrochloride (a derivative of Prazosin) is reported as an ingredient of Downat in the following countries:

• Japan

International Drug Name Search

Digton

Digton may be available in the countries listed below.

Ingredient matches for Digton

Sulpiride

Sulpiride is reported as an ingredient of Digton in the following countries:

• Spain

International Drug Name Search

Guanabenz Acetate

Ingredient matches for Guanabenz Acetate

Guanabenz

Guanabenz Acetate (USAN) is known as Guanabenz in the US.

International Drug Name Search

Glossary

USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Dipirona Magnesica

Dipirona Magnesica may be available in the countries listed below.

Ingredient matches for Dipirona Magnesica

Metamizole

Metamizole magnesium (a derivative of Metamizole) is reported as an ingredient of Dipirona Magnesica in the following countries:

• Colombia

International Drug Name Search

Nicabate

Nicabate may be available in the countries listed below.

Ingredient matches for Nicabate

Nicotine

Nicotine is reported as an ingredient of Nicabate in the following countries:

• Australia

Nicotine resinate (a derivative of Nicotine) is reported as an ingredient of Nicabate in the following countries:

• Australia

International Drug Name Search

Alrex

Alrex is a brand name of loteprednol ophthalmic, approved by the FDA in the following formulation(s):

ALREX (loteprednol etabonate - suspension/drops; ophthalmic)

• 
  Manufacturer: BAUSCH AND LOMB
  
  Approval date: March 9, 1998
  
  Strength(s): 0.2% ^[RLD]

Has a generic version of Alrex been approved?

No. There is currently no therapeutically equivalent version of Alrex available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Alrex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Soft steroids having anti-inflammatory activity
  Patent 4,996,335
  Issued: February 26, 1991
  Inventor(s): Bodor; Nicholas S.
  Assignee(s): Bodor; Nicholas S.
  The invention provides novel soft steroidal anti-inflammatory agents, pharmaceutical compositions containing said agents, and methods of administering same to mammals in the treatment of inflammation. Preferred compounds of the invention include haloalkyl 17.alpha.-alkoxycarbonyloxy-11.beta.-hydroxyandrost-4-en-3-one-17.beta.-ca rboxylates and the corresponding .DELTA..sup.1,4 compounds, optionally bearing 6.alpha.- and/or 9.alpha.-fluorine and 16.alpha.- or 16.beta.-methyl substituents. Especially preferred compounds include haloalkyl 17.alpha.-alkoxycarbonyloxy-9.alpha.-fluoro-11.beta.-hydroxy-16-methylandr osta-1,4-dien-3-one-17.beta.-carboxylates.
  
  Patent expiration dates:
  
  
  • March 9, 2012
    
  
  
  
  • September 9, 2012
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Suspension of loteprednol etabonate for ear, eye, or nose treatment
  Patent 5,540,930
  Issued: July 30, 1996
  Inventor(s): Guy; Yaacov J. & Friedman; Doron I.
  Assignee(s): Pharmos Corporation
  The invention provides novel compositions of matter containing water-insoluble steroid drugs suitable for therapeutic use. The invention provides stable aqueous suspensions of water-insoluble steroid drugs of particle sizes of .ltoreq.15 .mu.m which remain in such a state so as to allow for immediate suspension, when desired, even after extended periods of settling.
  
  Patent expiration dates:
  
  
  • October 25, 2013
    
  
  
  
  • April 25, 2014
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Suspension of loteprednol etabonate for ear, eye, or nose treatment
  Patent 5,747,061
  Issued: May 5, 1998
  Inventor(s): Amselem; Shimon & Friedman; Doron
  Assignee(s): Pharmos Corporation
  The invention provides novel compositions of matter for delivering water-insoluble steroid drugs suitable for therapeutic use. The invention also provides stable aqueous suspensions of water-insoluble steroid drugs of particle sizes of .ltoreq.30 .mu.m which remain in such a state so as to allow for immediate suspension, when desired, even after extended periods of settling.
  
  Patent expiration dates:
  
  
  • October 25, 2013
    
    ✓ 
    Patent use: ALREX OPTHALMIC SUSPENSION IS INDICATED FOR THE TEMPORARY RELIEF OF THE SIGNS AND SYMPTOMS OF SEASONAL ALLERGIC CONJUNCTIVITIS.
    ✓ 
    Drug product
  
  
  
  • April 25, 2014
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Alrex Drops Consumer Information (Wolters Kluwer)
• Alrex Consumer Information (Cerner Multum)
• Alrex Advanced Consumer Information (Micromedex)
• Loteprednol Drops Consumer Information (Wolters Kluwer)
• Loteprednol Ointment Consumer Information (Wolters Kluwer)
• Loteprednol ophthalmic Consumer Information (Cerner Multum)
• Loteprednol Ophthalmic Advanced Consumer Information (Micromedex)
• Loteprednol Etabonate AHFS DI Monographs (ASHP)

Mercuchrom

Mercuchrom may be available in the countries listed below.

Ingredient matches for Mercuchrom

Povidone Iodine

Povidone-Iodine is reported as an ingredient of Mercuchrom in the following countries:

• Germany

International Drug Name Search

Acénocoumarol

Acénocoumarol may be available in the countries listed below.

Ingredient matches for Acénocoumarol

Acenocoumarol

Acénocoumarol (DCF) is also known as Acenocoumarol (Rec.INN)

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Somatostatina Combino Pharm

Somatostatina Combino Pharm may be available in the countries listed below.

Ingredient matches for Somatostatina Combino Pharm

Somatostatin

Somatostatin x acetate (a derivative of Somatostatin) is reported as an ingredient of Somatostatina Combino Pharm in the following countries:

• Spain

International Drug Name Search

Plagril

Plagril may be available in the countries listed below.

Ingredient matches for Plagril

Clopidogrel

Clopidogrel is reported as an ingredient of Plagril in the following countries:

• Peru

Clopidogrel hydrogen sulfate (a derivative of Clopidogrel) is reported as an ingredient of Plagril in the following countries:

• Myanmar

International Drug Name Search

Nidilat

Nidilat may be available in the countries listed below.

Ingredient matches for Nidilat

Nifedipine

Nifedipine is reported as an ingredient of Nidilat in the following countries:

• Turkey

International Drug Name Search